Should there be a specific management for large cell neuroendocrine carcinoma?

G. Rossi (Modena, Italy)

Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Session: Neuroendocrine tumours of the lung
Session type: Symposium
Number: 1657
Disease area: Thoracic oncology

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Rossi (Modena, Italy). Should there be a specific management for large cell neuroendocrine carcinoma?. Annual Congress 2005 - Neuroendocrine tumours of the lung

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer
Source: Respipedia Article
Year: 2018

Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

Radiotherapy of nonsmall and small cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=190
Year: 2001

A novel biologic classification of non-small cell lung cancer
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Second line therapy for advanced non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015



Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006

Radiotherapy in the treatment of nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 207–243
Year: 2009

Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007


TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005